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Abstract 
Background: Malaria is endemic in 13 districts of Bangladesh. A baseline malaria prevalence survey across the endemic 
districts of Bangladesh was conducted in 2007, when the prevalence was reported around 39.7 per 1000 population. 
After two rounds of Global Fund to Fight AIDS, Tuberculosis and Malaria (GFATM)‑funded intervention by the National 
Malaria Control Programme (NMCP) and a BRAC‑led NGO consortium, a follow‑up survey was conducted across the 
malaria‑endemic districts of Bangladesh to measure the change in prevalence rate and in people’s knowledge of malaria.
Methods: The survey was carried out from August to November 2013 in 70 upazilas (sub‑districts) of 13 malaria‑
endemic districts of Bangladesh, following the same multi‑stage cluster sampling design and the same number of 
households enrolled during the baseline prevalence survey in 2007, to collect 9750 randomly selected blood samples. 
For on‑the‑spot diagnosis of malaria, a rapid diagnostic test was used. The household head or eldest person available 
was interviewed using a pre‑coded structured questionnaire to collect data on the knowledge and awareness of 
malaria in the household.
Results: Based on a weighted calculation, the overall malaria prevalence was found to be 1.41 per 1000 population. 
The proportion of Plasmodium falciparum mono‑infection was 77.78% while both Plasmodium vivax mono‑infection 
and mixed infection of the two species were found to be 11.11%. Bandarban had the highest prevalence (6.67 per 
1000 population). Knowledge of malaria signs, symptoms and mode of transmission were higher in the follow‑up 
survey (97.26%) than the baseline survey. Use of bed nets for prevention of malaria was found to be high (90.15%) 
at respondent level. People’s knowledge of selected parameters increased significantly during the follow‑up survey 
compared to the baseline survey conducted in 2007.
Conclusions: A reduced prevalence rate of malaria and increased level of knowledge were observed in the present 
malaria prevalence survey in Bangladesh.
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Background
Globally, 96 countries and territories are endemic for 
malaria with an estimated 3.2 billion people at risk. The 
World Health Organization (WHO) estimated 214 million 
malaria cases worldwide annually (uncertainty range 
149–303 million) with 438,000 deaths (uncertainty range 
236,000–635,000) in 2015 [1]. Among the ten malaria-
endemic countries of the WHO Southeast Asian region, 
Bangladesh is considered as hypo-endemic for malaria 
transmission where 90% of malaria is caused by Plasmo-
dium falciparum. In Bangladesh, 13 districts (out of 64) 
are endemic for malaria, all of which border India and/or 
Myanmar and almost 80% of malaria cases are reported 
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from three districts: Bandarban, Khagrachari and Ranga-
mati (collectively called Chittagong Hill Tracts (CHT)) [2].
Bangladesh received two grants from the Global Fund 
to Fight AIDS, Tuberculosis and Malaria (GFATM), 
Round 6 (in 2007) to scale-up malaria control interven-
tions, and another in 2009 (Round 9) for further expan-
sion of intervention coverage [3]. The Government of 
Bangladesh and an NGO consortium led by BRAC has 
been implementing this GFATM-funded malaria control 
programme in 13 malaria-endemic districts since 2007. 
As a result, malaria prevalence has decreased by 65%, 
severe malaria decreased by 79%, and malaria-associated 
mortality decreased by 91% from 2008 to 2012 [4].
A baseline malaria prevalence survey was conducted 
across 13 endemic districts of Bangladesh in 2007 by the 
same group of investigators, when the prevalence was 
reported around 39.7 per 1000 population. The majority 
of cases was found to be caused by P. falciparum (90.18%) 
followed by Plasmodium vivax (5.29%) and mixed infec-
tion (4.53%) by these two species [5].
To measure the change in prevalence rate and in 
people’s knowledge of malaria from 2007, a follow-up 
malaria prevalence survey was conducted across the 
malaria-endemic areas of Bangladesh. The results of the 
follow-up survey and some comparisons with the base-
line survey are presented here.
Methods
Study area
The survey was carried out in 70 upazilas (sub-districts) 
of 13 malaria-endemic districts of Bangladesh [5]. Epi-
demiologically, these districts can be divided into two 
groups: the CHT districts, where 80% of the country’s 
total malaria cases are reported every year, and the 
remainder (non-CHT). CHT is mostly hilly, forested 
and some parts are difficult to access [2]. Cox’s Bazar 
and Bandarban border Myanmar, Rangamati borders 
both India and Myanmar, while the rest of the malaria 
endemic districts share a border with India.
Sample size and sampling
The same multi-stage cluster sampling design as was 
used in the 2007 baseline survey was followed to test 
9750 individuals from an equal number of households 
[5]. Roughly, these prevalence surveys used a two-
stage cluster design. City corporations and towns were 
excluded. For each of the 13 districts, all mauzas (the 
lowest administrative unit of Bangladesh, mostly bigger 
than a village and with a polygon boundary) were listed 
and 30 clusters were selected using a probability propor-
tional to size (PPS) sampling procedure [6]. Information 
from the Bangladesh Bureau of Statistics was used to 
obtain the sampling frame for selection of the mauzas in 
each district. These mauzas were the primary sampling 
unit. All of the population, above one year old, irrespec-
tive of sex, religion or ethnicity, in a cluster were eligi-
ble to participate in the survey. Twenty-five households 
were selected using systematic random sampling from 
each cluster. As in the baseline survey [5], the household 
head or eldest person available was interviewed using a 
pre-coded, structured questionnaire to collect data on 
bed net use, knowledge and awareness to malaria by the 
household. For on-the-spot malaria diagnosis using rapid 
diagnostic test kit, one household member was chosen 
randomly from the available household members.
Ethical approval
The protocol was reviewed and approved by the institu-
tional research review committee and the ethical review 
committee of International Centre for Diarrhoeal Disease 
Research, Bangladesh (icddr,b). Written informed con-
sent was obtained from all adult subjects, and assent was 
obtained from legal guardians in the case of minor sub-
jects before starting of any study procedure.
Field operation
The survey was conducted from August to November 
2013. Households were selected systematically by the 
field team following a designated path using the ‘spin the 
bottle’ methodology [7] similar to the baseline survey [5].
All members of the household, including absentees, 
were listed. Only one individual (>one year) from a house-
hold was enrolled in this study using a simple randomiza-
tion procedure. Written informed consent or assent was 
obtained before proceeding with the survey activities. 
Selected individuals were tested for malaria and informa-
tion collected for any febrile illness in the previous 15 days.
Malaria diagnosis
One team member drew four to five drops of blood from 
randomly selected participants to perform malaria test by 
a rapid diagnostic test (RDT), prepare a slide smear (both 
thick and thin) for microscopic examination, and spot 
blood onto a filter paper for further molecular diagnosis. 
For on-the-spot malaria diagnosis from blood sample of 
the selected individual, a FalciVax (Zephyr Biomedicals, 
India) RDT was used. The same RDT was used during 
the baseline prevalence survey [5]. This specific RDT can 
detect both P. falciparum-specific antigen (HRP-2) and 
P. vivax-specific antigen (pLDH) from the blood sample. 
This RDT has also shown acceptable performance (more 
than 90% in both sensitivity and specificity) in a field 
evaluation in Bangladesh [8].
The test results were recorded by the field team on the 
record sheet. Patients diagnosed as having malaria were 
provided treatment as per national guideline.
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Quality control
The day-to-day field activities of the teams were ‘fine-
tuned’ by field researchers based in local offices. The 
investigators from central office at Dhaka made fre-
quent field visits for on-spot checking of the quality of 
interviews and to provide assistance and guidance when 
needed. Whenever required, re-interviewing was car-
ried out by the supervisors to secure reliable and valid 
data.
Data management and analysis
All data from the field were recorded on pre-coded, paper-
based forms, which were designed for direct data entry 
using a scanner. Field workers were trained to use the 
forms so that information could be read easily. ABBYY 
FlexiCapture 8.0 (ABBYY 3A, Otradnaya str. 2b/6, 127,273, 
Moscow, Russia) software for electronic data capturing 
and processing was used for data capturing. Data were 
then exported to a Microsoft Office Access 2011 data-
base. The data files were maintained at the data centre in 
Dhaka and Bandarban. Images of the scanned data forms 
were maintained in digital format in case there was a need 
to inspect the primary data source. For data analysis ‘svy’ 
command of STATA (Version 11, StataCorp LP, TX, USA) 
was used. All results were weighted (weight  =  1/prob-
ability of selection) to account for unequal probabilities of 
selection of clusters across district. Bivariate analysis was 
performed to determine the change regarding knowledge 
level of a respondent. A proportion test was used to detect 
any change in knowledge level between the baseline sur-
vey in 2007 and the present survey (2013). Differences 
between proportions were measured by one-tailed test in 
5% (P < 0.05) level of significance.
Results
Malaria prevalence
Among the 13 malaria-endemic districts, the overall, unad-
justed, malaria prevalence rate was 0.92 per 1000 popula-
tion. The prevalence of P. falciparum mono-infection was 
0.72 per 1000 population and 0.10 per 1000 population for 
P. vivax mono-infection, while for mixed infection with 
P. falciparum and P. vivax the prevalence was 0.10 per 
1000 population. The proportion of P. falciparum mono-
infection was 77.78% while for P. vivax mono-infection the 
proportion was 11.11% and for mixed infection the pro-
portion was 11.11% in both cases. No significant difference 
in prevalence of malaria was detected with regard to the 
gender of study participants. Bandarban was the district 
with the highest prevalence (6.7 per 1000 population) fol-
lowed by Cox’s Bazar (2.7 per 1000 population).
When considering the age group, children under five 
years of age were found to have a higher prevalence (7.37 
per 1000) than the other groups. The average weighted 
malaria prevalence in CHT was 1.71 per 1000 popula-
tion and in non-CHT districts 1.30 per 1000 population. 
Prevalence of malaria among symptomatic (febrile) indi-
viduals was 4.91 per 1000 population and 0.59 per 1000 
population among asymptomatic individuals. Weighted 
prevalence of malaria according to infection type, gen-
der, age group, area, and study participants are given in 
Table 1. Weighted prevalence of malaria in endemic areas 
of Bangladesh found in this survey is shown in Fig. 1.
Table 1 Prevalence of malaria (weighted) according to infection type, gender, age group, area, and study participants
Prevalence (per thousand)
Any Plasmodium infection  
[95% CI]
Pf infection [95% CI] Pv infection [95% CI] Mixed (pf and pv) 
infection %[95% CI]
Overall 1.41 (0.56–3.50) 0.87 (0.31–2.44) 0.06 (0.01–0.41) 0.48 (0.07–3.40)
By Sex
 Male 2.38 (0.76–7.45) 2.38 (0.76–7.45) 0 (0,0) 0 (0,0)
 Female 0.94 (0.21–4.28) 0.15 (0.02–1.04) 0.09 (0.01–0.61) 0.71 (0.10–5.03)
By age group (years)
 <4 7.37 (1.03–50.58) 7.37 (1.03–50.58) 0 (0) 0 (0)
 5–14 0 (0) 0 (0) 0 (0) 0 (0)
 15–49 1.76 (0.64–4.86) 1.00 (0.29–3.44) 0.08 (0.01–0.59) 0.68 (0.10–4.81)
 ≥50 0.34 (0.05–2.35) 0.34 (0.05–2.35) 0 (0) 0 (0)
By area
 CHT 1.71 (0.77–3.78) 1.48 (0.61–3.58) 0.23 (0.03–1.67) 0 (0)
 Non CHT 1.30 (0.36–4.65) 0.66 (0.12–3.61) 0 (0) 0.64 (0.09–4.57)
Type of participants
 Symptomatic 4.91 (1.71–13.96) 2.37 (1.06–5.29) 0 (0) 2.53 (0.37–17.20)
 Asymptomatic 0.59 (0.10–3.35) 0.52 (0.07–3.68) 0.07 (0.01–0.51) 0 (0)
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Knowledge of malaria
Malaria awareness-related responses are summarized in 
Table 2. People in CHT were found to have better malaria 
awareness than non-CHT areas. It was found that most 
households knew about malaria (97.76%). Most of the 
respondents (97.26%) also knew fever as the cardinal sign 
Fig. 1 Prevalence (weighted) of malaria in endemic areas of Bangladesh in 2013
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for malaria. The respondents’ awareness about malarial 
illness as well as its cause (mosquito bite) was very high 
(95.02%).
Use of insecticide-treated bed nets (ITN) was found a 
preferred method for prevention (>90%). However, peo-
ple in CHT (75.87%) thought ITN could be a better pre-
ventive method than non-CHT areas (25.13%).
People in CHT knew both public health facilities 
(70.18%) and NGO workers (76.53%) were among the 
preferred options for treatment. In non-CHT areas only 
44.33% people knew about NGO workers, who provide 
malaria diagnosis and treatment. The majority of the 
respondents knew that treatment of malaria (78.78%) was 
provided free of cost (Table 2). All these better responses 
were found among respondents in CHT than in non-
CHT (Table  2) but this difference was not found to be 
statistically significant.
People’s knowledge of symptoms of malaria as fever, 
transmission by mosquito bites, prevention by using bed 
net, ITN and mosquito-repellent coils, and preference 
to government hospital or partner NGO for treatment, 
was found to be increased significantly during follow-up 
survey in 2013 compared to the baseline survey in 2007 
(Table 3).
Discussion
Bangladesh is among the six Southeast Asian countries to 
report at least 75% decrease in malaria incidence of con-
firmed cases due to delivery of vector control interven-
tions (ITNs or indoor residual spraying (IRS)) to protect 
more than 60% of its population at high risk between 2000 
and 2014 [1]. Following the last few years of GFATM-sup-
ported control initiatives, Bangladesh has made signifi-
cant progress in malaria control. The study documents the 
reduction of the prevalence rate of malaria infection and 
increased knowledge of malaria by the endemic population 
of Bangladesh compared to the baseline survey conducted 
in 2007 [5]. High coverage of and increased use of ITN, 
RDTs and anti-malarial treatment with artemisinin com-
bination therapy (artemether–lumefantrine), and the high 
number of community health workers and health facilities, 
has contributed significantly to this achievement [4]. For 
the same reason low malaria prevalence has been observed 
in many countries, such as reported in Eritrea [9].
As there is a possibility of the presence of asympto-
matic malaria cases, as seen in previous observations 
in Bandarban district of CHT [10, 11], it could not be 
overruled that a PCR-based molecular diagnosis would 
be useful to detect asymptomatic individuals within the 
population surveyed in the study. In Cambodia by PCR, 
overall malaria prevalence was found to be almost 2.5-
fold higher than was estimated by RDT [12]. Thus, the 
major constraint of the present report is the absence of 
supporting evidence from molecular tests such as PCR. 
On the other hand, there is a rare possibility of low 
positivity in RDT due to intra-specific variation in gene 
encoding the HRP(Histidine-rich protein) [13] or dele-
tion of the gene [14] among P. falciparum isolates. There 
is documentation of low positivity in RDT recently in 
the Sylhet area of Bangladesh due to deletion of the gene 
(unpublished data); the sequence is reported to the Gen-
bank (accession number: KH388531).
Table 2 Malaria awareness characteristics of  the study 
population by study areas, N(%)
Characteristics CHT Non-CHT All
Have heard about malaria
 Yes 2208 (98.13) 7324 (97.65) 9532 (97.76)
 No 42 (1.87) 174 (2.32) 216 (2.22)
 Don’t know 0 2 (0.03) 2 (0.02)
Symptoms of malaria
 Fever 2184 (97.07) 7299 (97.32) 9483 (97.26)
 Fever with shivering 131 (5.82) 428 (5.71) 559 (5.73)
 Don’t know 53 (2.36) 190 (2.53) 243 (2.49)
 Others 43 (1.91) 5 (0.07) 48 (0.49)
Causes of malaria
 Mosquito bite 2153 (95.69) 7111 (94.81) 9264 (95.02)
 Fly/insect bite 14 (0.62) 10 (0.13) 24 (0.25)
 Not maintaining neat and 
cleanliness
62 (2.76) 81 (1.08) 143 (1.47)
 Don’t know 81 (3.60) 351 (4.68) 432 (4.43)
 Others 0 0 0
How to prevent malaria
 Preventing breeding of 
mosquito
585 (26.00) 488 (6.51) 1073 (11.01)
 Using bed‑net 1890 (84.00) 6900 (92.00) 8790 (90.15)
 Using insecticide impreg‑
nated bed‑net
1707 (75.87) 1885 (25.13) 3592 (36.84)
 Using mosquito repellent/
coil
400 (17.78) 2198 (29.31) 2598 (26.65)
 Don’t know 49 (2.18) 226 (3.01) 275 (2.82)
 Others 52 (2.31) 48 (0.64) 100 (1.03)
Place of seeking treatment
 Public hospital/health centre 1579 (70.18) 5115 (68.20) 6694 (68.66)
 Private health centre 185 (8.22) 890 (11.87) 1075 (11.03)
 Village doctors 280 (12.44) 890 (11.87) 1170 (12.00)
 Drug store sales people 259 (11.51) 438 (5.84) 697 (7.15)
 NGO 1722 (76.53) 3325 (44.33) 5047 (51.78)
 Don’t know 40 (1.78) 651 (8.68) 691 (7.09)
 Others 32 (1.42) 87 (1.16) 119 (1.22)
Have to spend money for malaria treatment?
 Yes 169 (7.51) 1256 (16.75) 1425 (14.62)
 No 2070 (92.00) 5611 (74.81) 7681 (78.78)
 Don’t know 11 (0.49) 633 (8.44) 644 (6.61)
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Overall, knowledge of malaria transmission has 
improved since the baseline survey [15] as evident from 
the present survey. It is understandable that in malaria-
endemic communities, with ongoing control activities, 
increased knowledge should prevail. This was found to be 
the case in this survey as well as in Swaziland [16], Ethiopia 
[17], Eritrea [9], and Nigeria [18]. Knowledge on the use of 
ITN as a preventive measure against mosquito bites was 
found to be significantly higher among respondents in this 
follow-up study compared to the baseline survey (Table 3) 
[15]. This level of knowledge on preventive use of ITN has 
also been observed in Colombia [19], Nepal [20], Eritrea 
[9], and Ghana [21] while a lower level of knowledge was 
observed in India [22], Iran [23] and Turkey [24].
It has been observed that artemisinin-based combi-
nation therapy remains highly effective for the treat-
ment of malaria caused by P. falciparum  in Bangladesh 
[25]. However, the greatest threat to the malaria control 
programme in Bangladesh remains the increasing arte-
misinin resistance emerging in Southeast Asia. There, 
two independent foci of resistance based on K13-propel-
ler mutations in P. falciparum have been identified, one 
of which includes Cambodia, Vietnam and Laos and the 
other includes western Thailand, Myanmar and China 
[26]. Moreover, it has been reported that the K13-propel-
ler mutations in P. falciparum reached high prevalence 
in Myanmar, next to the northwestern border with India 
[27]. Such emergence of artemisinin resistance to P. falci-
parum strains in neighbouring India and Myanmar could 
be transmitted through malaria vectors active in remote 
border areas of Bangladesh [28, 29].
Reported resistance to pyrethroids by malaria vectors 
can be seen as another important obstacle to malaria 
control activities in future. Bangladesh, along with its 
neighbours India and Myanmar, has reported malaria 
vector resistance to pyrethroids, the main insecticide 
group used in ITN by control programmes [1].
Conclusions
Reduction of malaria prevalence and an increased level 
of awareness of malaria has a positive health impact 
through active collaboration between NMCP, GoB (Gov-
ernment of Bangladesh) and NGO partners in Bangla-
desh. Involvement of community participation is crucial, 
not only to sustain this achievement but for its further 
enhancement. Efforts should be made to continue ongo-
ing malaria control activities with the aim of eliminating 
malaria from endemic areas.
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Table 3 Comparison of people’s knowledge between baseline prevalence survey in 2007 and follow up survey in 2013
Variables Malaria survey 2007 (µ1) Malaria survey 2013 (µ2) P value
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How do you know that you have got malaria?
 Fever 0.943 (0.939–0.948) 0.990 (0.988–0.992) <0.001
 Others 0.135 (0.128–0.142) 0.071 (0.066–0.076) <0.001
Why someone gets malaria?
 Mosquito bite 0.943 (0.938–0.948) 0.965 (0.961–0.969) <0.001
 Fly/insect bite 0.031 (0.027–0.034) 0.002 (0.001–0.003) <0.001
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 Others 0.043 (0.039–0.047) 0.030 (0.026–0.033) <0.001
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 Using bed net 0.854 (0.847–0.862) 0.914 (0.908–0.920) <0.001
 Using insecticide bed‑net 0.017 (0.014–0.020) 0.376 (0.366–0.386) <0.001
 Coil 0.187 (0.180–0.195) 0.269 (0.260–0.278) <0.001
 Others 0.108 (0.101–0.114) 0.025 (0.022–0.028) <0.001
Where you can get this treatment?
 Govt. hospital 0.677 (0.668–0.686) 0.696 (0.687–0.705) <0.001
 Private health centre 0.206 (0.198–0.214) 0.112 (0.106–0.118) <0.001
 Village doctors 0.387 (0.377–0.397) 0.121 (0.115–0.128) <0.001
 Drug stores 0.294 (0.285–0.303) 0.072 (0.067–0.077) <0.001
 NGO 0.245 (0.237–0.254) 0.548 (0.538–0.558) <0.001
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